Equities

Together Pharma Ltd

Together Pharma Ltd

Actions
IndustrialsConstruction & Materials
  • Price (ILa)265.00
  • Today's Change6.90 / 2.67%
  • Shares traded180.53k
  • 1 Year change-51.28%
  • Beta-0.0303
Data delayed at least 20 minutes, as of Apr 02 2020 10:54 BST.
More ▼

Profile data is unavailable for this security.

About the company

Together Pharma Ltd, formerly Together Startup Network Ltd, is an Israel-based company that develops technologies for online recruitment. The Company has the following products: ExactMe, which is a search engine used by recruiters to search for jobseekers; POP CV, which is a curriculum vitae center system that assesses, ranks and matches resumes that are sent to the employer, as well as SkilliQ, which is a job board.

  • Revenue in ILS (TTM)0.00
  • Net income in ILS-15.10m
  • Incorporated1991
  • Employees6.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TGTR:TLV since
announced
Transaction
value
Cannabliss LtdDeal completed13 Jun 201913 Jun 2019Deal completed-38.08%4.16m
Data delayed at least 20 minutes, as of Apr 02 2020 10:54 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Algomaizer Ltd174.75m-4.33m37.49m10.00--4.7319.050.2145-0.1888-0.18887.670.3002.33--6.62---5.77-54.27-12.87-103.1425.0825.99-2.48-32.82--0.59480.7361--167.06206.0069.91--46.41--
Capital Point Ltd0.00-4.31m38.02m14.00--0.2473-----0.035-0.0350.001.250.00-------2.363.60-2.684.06------384.09----0.1226-------16.39---29.52--
Top Ramdor Systems and Comp Co 1990 Ltd127.19m6.28m64.24m187.009.641.775.380.50510.31470.31476.341.711.28--3.22--6.278.5412.6618.3133.8235.344.896.93--4.640.478148.1726.0313.2211.8224.8136.5113.25
Babylon Ltd6.77m5.42m88.89m24.0015.940.704416.3713.140.10690.10690.13362.420.0518--7.57--4.148.504.479.0878.7883.1480.0534.34----0.00236.25-93.36-76.52-877.93------
Foresight Autonomous Holdings Ltd0.00-55.62m95.64m3.00--1.62-----0.3778-0.37780.000.3810.00-------69.87-70.23-75.57-74.50-----------36.660.0801-------5.34------
Somoto Ltd174.64m32.26m97.88m--3.050.83142.220.56040.4450.4452.441.630.9787--5.06--18.088.6324.9312.6056.6649.5518.478.96----0.1143---16.0519.7350.6523.8114.56--
Amanet Management & Systems Ltd.348.35m41.74m111.36m2.70k2.670.90282.380.31976.276.2752.3718.541.84--3.79--22.677.6937.6313.306.837.1312.293.93----0.071977.157.324.78-35.500.4265-20.740.495
ORT Technologies Ltd5.73m-5.08m117.61m20.00--0.604--20.54-1.03-1.311.1640.390.02383.271.94---2.11-1.40-2.33-2.41-37.100.1253-88.65-35.937.49--0.00---36.67-54.54-142.80---73.91--
Together Pharma Ltd0.00-15.10m143.72m6.00---------0.3206-0.32060.00-0.39570.00-------78.40-338.17-105.16-737.98-------844.380.7332-2.051.85-------5,251.62--206.36--
Data as of Apr 02 2020. Currency figures normalised to Together Pharma Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

1.18%Per cent of shares held by top holders
HolderShares% Held
IBI Mutual Funds Management (1978) Ltd.as of 29 Aug 2019428.63k0.77%
Meitav Ds Mutual Funds Ltd.as of 29 Aug 2019132.81k0.24%
Ayalon Financial Solutions (2004) Ltd.as of 29 Aug 201992.89k0.17%
Data from 29 Aug 2019 - 31 Dec 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.